Literature DB >> 20392313

Vitamin D supplementation in young children: associations with Theory of Planned Behaviour variables, descriptive norms, moral norms and habits.

Jascha de Nooijer1, Monique Onnink, Patricia van Assema.   

Abstract

OBJECTIVE: In the Netherlands, a supplementation of 10 microg vitamin D is recommended for children (aged 0-4 years), given that vitamin D contributes to the development of healthy bones and deficiency during childhood is a risk factor for osteoporosis at a later age. However, only 60 % of the Dutch children receive sufficient vitamin D supplementation a day. In order to develop interventions to improve supplementation intake, it is necessary to gain insight into the behaviour of parents in giving their children vitamin D supplementation and its association with variables of the Theory of Planned Behaviour, moral and descriptive norms and habits.
DESIGN: A cross-sectional survey to assess present supplementation-related behaviour, knowledge, received information, intention, attitude, subjective norm, perceived behavioural control, moral norm, descriptive norm and habit.
SETTING: Data obtained from a representative Internet Panel by means of electronic questionnaires.
SUBJECTS: Parents (n 270) of children aged 0-4 years.
RESULTS: Half of the parents (48.9 %) gave their child sufficient vitamin D supplementation. Giving the supplement at a fixed time, a positive intention and habit were significantly associated with actual behaviour. The higher age of the child, first-born status, a fixed time for taking vitamin supplementation, descriptive norm and moral obligation were significantly associated with intention.
CONCLUSIONS: These results indicate that because many parents do not give their children adequate vitamin D supplementation, the promotion of supplementation during the first years of life is a necessity. Effective yet simple strategies should be developed, focused on improving moral obligation, descriptive norms and habit formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392313     DOI: 10.1017/S1368980010000777

Source DB:  PubMed          Journal:  Public Health Nutr        ISSN: 1368-9800            Impact factor:   4.022


  7 in total

Review 1.  Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.

Authors:  Maren Preis
Journal:  AAPS PharmSciTech       Date:  2015-03-05       Impact factor: 3.246

2.  Adherence to the infant vitamin D supplementation policy in Ireland.

Authors:  A Hemmingway; D Fisher; T Berkery; D M Murray; M E Kiely
Journal:  Eur J Nutr       Date:  2020-07-17       Impact factor: 5.614

3.  Acceptability of different oral formulations in infants and preschool children.

Authors:  Diana A van Riet-Nales; Barbara J de Neef; Alfred F A M Schobben; José A Ferreira; Toine C G Egberts; Catharine M A Rademaker
Journal:  Arch Dis Child       Date:  2013-07-13       Impact factor: 3.791

4.  The use of implementation intentions to promote vitamin D supplementation in young children.

Authors:  Jascha de Nooijer; Roos Jansen; Patricia van Assema
Journal:  Nutrients       Date:  2012-10-12       Impact factor: 5.717

5.  Effect of Low-Dose Vitamin D Supplementation on Serum 25(OH)D in School Children and White-Collar Workers.

Authors:  Ronghua Zhang; Xiamusiye Muyiduli; Danting Su; Biao Zhou; Yueqiang Fang; Shuying Jiang; Shuojia Wang; Lichun Huang; Minjia Mo; Minchao Li; Bule Shao; Yunxian Yu
Journal:  Nutrients       Date:  2017-05-17       Impact factor: 5.717

6.  Vitamin D intake of Dutch infants from the combination of (fortified) foods, infant formula, and dietary supplements.

Authors:  Janneke Verkaik-Kloosterman; Marja H Beukers; Martine Jansen-van der Vliet; Marga C Ocké
Journal:  Eur J Nutr       Date:  2015-11-24       Impact factor: 5.614

7.  Determinants of Vitamin D Supplementation among Individuals with Type 1 Diabetes.

Authors:  Mikołaj Kamiński; Magdalena Molenda; Agnieszka Banaś; Aleksandra Uruska; Dorota Zozulińska-Ziółkiewicz
Journal:  Int J Environ Res Public Health       Date:  2020-01-22       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.